Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
The biopharma world's manufacturing weekly
Manufacturing channel feed
Roche could rethink $50B US expansion plan if new policies 'harm' operations
Last month
Pharma
Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi
Last month
Pharma
Lonza says its US-based sites are in high demand as pharma tariffs near
Last month
Pharma
Bristol Myers' $40B US investment; Shionogi to buy Japanese drugmaker
Last month
Gilead reveals plans to put another $11B into US manufacturing
Last month
R&D
Pharma
Teva plans staff cuts as it commits to accelerating growth
Last month
Pharma
PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments
Last month
Pharma
Charles River launches ‘strategic review’ alongside activist investor Elliott
Last month
Outsourcing
Trump, FDA zero in on foreign factories to give domestic sites an edge
Last month
Pharma
FDA+
Investors unveil plans for $1.3B cancer hub in London suburbs
Last month
R&D
Bristol Myers to close cell therapy site in Illinois as part of ongoing cost cuts
Last month
People
Cell/Gene Tx
Lilly CEO Ricks urges Trump to drop drug tariff plan
Last month
Pharma
GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says
Last month
Pharma
Merck plans to bring Keytruda production to the US with $1B biologics factory
Last month
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near
Last month
China
Pharma
WuXi AppTec sees growth after 2024 dip, plans ‘lean’ operations to temper ‘external opportunities’
Last month
China
Pharma
Daiichi Sankyo says production boost in US will help cushion tariff impact
Last month
Pharma
AbbVie commits $10B to expand US footprint with the threat of tariffs ahead
Last month
Pharma
Amgen invests $900M to expand Ohio biomanufacturing
Last month
Lotte Bio launches ADC services; Ypsomed to focus on self-injection business
Last month
Thermo Fisher buckles up for US-China trade war, budgets $2B to ease impact
Last month
China
Pharma
Regeneron to boost its US manufacturing through a $3B Fujifilm deal
Last month
Pharma
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs
Last month
China
Pharma
Updated: Roche’s $50B US investment includes previous build announcements
Last month
Pharma
First page
Previous page
1
2
3
4
5
Next page
Last page